Study of the efficacy of the acute phase therapy for Kawasaki disease based on a new Shizuoka protocol 2016

Study of the efficacy of the acute phase therapy for Kawasaki disease based on a new Shizuoka protocol 2016 - Multicenter Study of the therapy for Kawasaki disease by Shizuoka protocol 2016

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000025707

Enrollment

500

Registered

2017-02-01

Start date

2017-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kawasaki disease

Interventions

A subject is treated with IVIG at the 1st step. If the subject is resistant to the 1st IVIG, 2nd IVIG is administered at the 2nd step. In case the subject is predicted to be resistant to the 2nd IVIG

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who are diagnosed as Kawasaki disease and agree to participate in this study

Exclusion criteria

Exclusion criteria: Patients who are diagnosed as Kawasaki disease but refuse to participate in this study.

Design outcomes

Primary

Measure	Time frame
The effectiveness is estimated by the incidence of CAL one month after onset.	—

Countries

Japan

Contacts

Public ContactSatoru Iwashima

Chutoen Central Medical Center Department of Pediatrics

iwashima3617@gmail.com0537-21-5555

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026